Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1983-08-18
1987-03-17
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Lymphokine
530389, 530391, A61K 39395
Patent
active
046506756
ABSTRACT:
Conjugate composed of an oligonucleotide covalently bonded to a carrier.
REFERENCES:
patent: 3725545 (1973-04-01), Maes
patent: 3821193 (1974-06-01), Fare et al.
patent: 4372883 (1983-02-01), Matuhashi et al.
patent: 4388306 (1983-06-01), Field et al.
patent: 4400375 (1983-08-01), Douthort et al.
patent: 4460575 (1984-07-01), d'Hinterlord et al.
patent: 4472301 (1984-09-01), Buckler et al.
Yves Borel et al. (1973), American Association for the Advancement of Science, 182 76-78.
Papalian et al. (1980) J. Clin Invest., 65 469-477.
Borel et al. (1980) Proc. Natl. Acad. Sci. 77 1593-6.
Golan et al. (1971) The Journal of Experimental Medicine, 134 1046-1061.
Molin et al. (1978) The Journal of Histochemistry and Cytochemistry 26 1053-6.
Ellis et al. (1976) Progress in Medicinal Chemistry, 13 272-301.
Hopwood, David, Histochemical Journal, 7 (1975) 267-276.
Borel Helina
Borel Yves
Gallop Paul M.
Stollar B. David
Hazel Blondel
The Children's Medical Center Corporation
LandOfFree
Oligonucleotide conjugates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotide conjugates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotide conjugates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1787782